Cerebellar Scholars' Challenging Time in COVID-19 Pandemia.
Journal
Cerebellum (London, England)
ISSN: 1473-4230
Titre abrégé: Cerebellum
Pays: United States
ID NLM: 101089443
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
pubmed:
18
4
2020
medline:
7
5
2020
entrez:
18
4
2020
Statut:
ppublish
Résumé
Novel coronavirus, SARS-CoV2, has caused pandemic of highly contagious disease called coronavirus disease 2019 (COVID-19), with epicenters in China, Italy, Spain, and the USA. Primarily affecting the human respiratory system, SARS-CoV2 has some impact on the human brain, but apparently minimal on the cerebellum, at least so far. Neurological involvement in the acute phase appears to manifest with confusion, dizziness, impaired consciousness, propensity to develop acute strokes, anosmia, hypogeusia, ataxia, epilepsy, and neuralgia. Cerebellar scholars are facing a time of uncertainty. Telemedicine has suddenly emerged as an alternative to follow patients. There is an urgent need to develop novel platforms to assess and follow ataxic patients remotely, especially because cerebellar patients often require ambulatory care to maintain their autonomy.
Identifiants
pubmed: 32301047
doi: 10.1007/s12311-020-01131-9
pii: 10.1007/s12311-020-01131-9
pmc: PMC7161715
doi:
Types de publication
Editorial
Langues
eng
Sous-ensembles de citation
IM
Pagination
343-344Références
Clin Infect Dis. 2020 Jul 28;71(15):889-890
pubmed: 32215618
J Med Virol. 2020 Jun;92(6):552-555
pubmed: 32104915
ACS Chem Neurosci. 2020 Apr 1;11(7):995-998
pubmed: 32167747
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143